Here are relevant reports on : digital-human-market

• Enterprise Content Management Market by Offering (Solutions [Document Management, Record Management], Services), Business Function (Sales & Marketing, Human Resources), Deployment Mode, Organization Size, Vertical, and Region - Global Forecast to 2031

  The global enterprise content management (ECM) market is projected to grow from USD 59.53 billion in 2026 to USD 95.76 billion by 2031 at a compounded annual growth rate (CAGR) of 10.0% during the forecast period. Some of the significant enterprise content management vendors include Microsoft (US), OpenText (Canada), Box (US), Hyland (US), IBM (US), Adobe (US), Xerox (US), Atlassian (Australia), KYOCERA Corporation (Japan), and Oracle (US).

  • Published: June 2026
  • Price: $ 4950
  • TOC Available:

• North America Probiotics Market by Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Forecast to 2030

  The North America probiotics market is estimated to be USD 14.78 billion in 2025 and is projected to reach USD 21.92 billion by 2030, at a CAGR of 8.2% from 2025 to 2030. The Key ADM (US), Probi USA Inc. (US), Danone North America Public Benefit Corporation (US), International Flavors & Fragrances Inc. (US), Nestle USA (US), Lifeway Foods, Inc. (US), Lactalis American Group, Inc. (US), Kerry Group plc. (Ireland), Now Foods (US), Nature’s Bounty (US), Renewlife (US), Garden of Life (US), Jarrow Formulas, Inc. (US), Kevita (US), and Chobani, LLC. (US).

  • Published: June 2026
  • Price: $ 4950
  • TOC Available:

• Disclosure Management Market by Business Function (Finance, Legal, Marketing and Communication, Compliance, Procurement, and Human Resource), Component (Software and Services), Deployment Type, Organization Size, and Vertical - Global forecast to 2022

  The disclosure management market accounted for USD 433.0 Million in 2016 and is projected to reach USD 1,066.0 Million by 2022, growing at a Compound Annual Growth Rate (CAGR) of 16.7% during 2017–2022. The major growth drivers of the disclosure management market include the increasing need to comply with regulatory bodies, and globalization of businesses. The base year considered for this report is 2016, and the market forecast period considered is 2017–2022. The major vendors providing disclosure management software and services are SAP (Germany), Oracle (US), Certent (US), IRIS Business Services (India), Workiva (US), CoreFiling (UK), DataTracks (India), LucaNet (Germany), OCR Services (US), Trintech (Australia), and Lecorpio (US).

  • Published: March 2018
  • Price: $ 4950
  • TOC Available:

• North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031

  North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics.

  • Published: June 2026
  • Price: $ 4950
  • TOC Available:

• Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031

  The human microbiome drugs market, valued at US$0.09 billion in 2024, stood at US$0.35 billion in 2025 and is projected to advance at a resilient CAGR of 35.2% from 2025 to 2031, culminating in a forecasted valuation of US$2.13 billion by the end of the period. The human microbiome drugs market is growing, driven by the increasing clinical success of live biotherapeutic products, rising prevalence of chronic and recurrent diseases, and expanding therapeutic applications beyond gastrointestinal disorders into metabolic, immune, and neurological conditions.

  • Published: June 2026
  • Price: $ 4950
  • TOC Available:

• Asia Pacific Human Microbiome Market by Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031

  The Asia Pacific Human Microbiome Market, valued at US$0.19 billion in 2024, stood at US$0.26 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end of the period. Market growth is driven by an increasing focus on preventive and personalized health, rising adoption of microbiome-based diagnostics and therapeutic solutions, and rapid advances in next-generation sequencing, AI-enabled microbiome analytics, and regional bioinformatics capabilities.

  • Published: June 2026
  • Price: $ 4950
  • TOC Available:

• Europe Probiotics Market by Product Type (Functional Food & Beverages, Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Forecast to 2030

  The Europe probiotics market is estimated to be USD 15.73 billion in 2025 and is projected to reach USD 20.56 billion by 2030, registering at a CAGR of 5.5% from 2025 to 2030. The key players such as Danone S.A. (France), Probi AB (Sweden), Nestlé S.A. (Switzerland), Kerry Group plc (Ireland), BioGaia AB (Sweden), Bio-K Plus International Inc. (Canada), Daflorn Probiotics Ltd. (Bulgaria), Yakult Honsha Co., Ltd. (Japan), Arla Foods (Denmark), and AB-Biotics S.A. (Spain).

  • Published: July 2026
  • Price: $ 4950
  • TOC Available:

• Process Orchestration Market by Component, Business Function (Supply Chain Management and Order Fulfillment, Marketing, and Human Resource Management), Deployment Type, Organization Size, Industry Vertical, and Region - Global Forecast to 2023

  The process orchestration market is expected to grow from USD 3.79 billion in 2018 to USD 8.50 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 17.5% during the forecast period. Several factors that are expected to drive the process orchestration market include the integration of Artificial Intelligence (AI) and Machin Learning (ML) technologies with the process orchestration solution, demand for IT resources according to business priorities, and improved IT systems to meet customers’ dynamic requirements. Industry verticals such as Banking, Financial Services, and Insurance (BFSI), and consumer goods and retail are expected to have significantly contributed to the growth of the process orchestration market. Major vendors who offer process orchestration solution and services across the globe include SAP (Germany), IBM (US), Oracle (US), CA Technologies (US), ServiceNow (US), Cisco (US), BMC Software (US), Fujitsu (Japan), OpenText (Canada), TIBCO (US), Software AG (Germany), HCL (India), Wipro (India), Newgen Software (India),Everteam (France), Arvato (Germany), Ayehu (US), Micro Focus (UK), Icaro Tech (Brazil), Cortex (UK), eQ Technologic (US), PMG (US), Nipendo (US), Dealflo (UK), and Data Ductus (Sweden).

  • Published: June 2018
  • Price: $ 4950
  • TOC Available:

• Primary Cells Market by Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Pharma Biotech, CROs, Academia), Region - Global Forecast to 2028

  The global primary cells market, valued at US$1.5 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 10.5% from 2023 to 2028, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The growth of this market can be attributed to factors such as the is the growing advantages of primary human cells over cell lines, rising growth in pharmaceutical & biotechnology industries, increasing demand for monoclonal antibodies, Government investments for cell-based research, and increasing cancer research.

  • Published: July 2023
  • Price: $ 4950
  • TOC Available:

• Industrial Software Market by Type (Manufacturing Execution System, SCADA, Human Machine Interface, Robotic Software, Fault Detection and Classification, Al in manufacturing, Industrial Metrology), End-use (Process, Discrete) - Global Forecast to 2029

  The global industrial software market is expected to grow from USD 21.5 billion in 2024 to USD 46.6 billion by 2029, at a compound annual growth rate (CAGR) of 16.7 % during the forecast period.The key players Siemens (Germany), Rockwell Automation (US), ABB (Switzerland), Emerson Electric Co. (US) and General Electric (US).

  • Published: June 2024
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50